Decline in global pharma industry sales force levels
Cegedim Strategic Data (CSD), a global provider of health care research data and services, reports that there has been a 1.2% decline in 2013 in worldwide pharmaceutical industry sales force levels.
Decreases were most notable in North America where total full time rep equivalents (FTEs) stood at 66,000 as of fourth-quarter 2013, representing a drop of 7.4% over the previous 12 month period. Similarly, FTE audits for the top 5 five European markets (France, Germany, Italy, UK and Spain) showed a decline of 7% to 72,000 reps. These regional trends reveal a continuation of cuts, although at a slower rate since 2012.
CSD's measurement of 2013 sales force levels shows a continuation of regional trends seen in 2012. Worldwide, sales force levels were down slightly at 424,000 FTEs - a 1.2% drop compared to 2012.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze